{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:18:09Z","timestamp":1791271089015,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The nucleotides associated with Tamm\u2010Horsfall protein (THP) identified in this study are 2\u2032(3\u2032) isomers, which are uncommon and very little is known about their biochemical pathway and role in interstitial cystitis (IC). The current study provides additional evidence of our earlier finding that THP is abnormal in IC patients. This can adversely affect THP's protective function, and suggests that THP plays a role in the pathogenesis of the disease.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To identify and characterise\n                            <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                            amm\u2010\n                            <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>\n                            orsfall protein (\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            )\u2010associated metabolites present in patients with interstitial cystitis (\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            ). Identification of these metabolites would give us insight into the complex interaction of\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            with urinary metabolites and its effect on the protective function of\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients, Subjects and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            T\n                            <jats:styled-content style=\"fixed-case\">HP<\/jats:styled-content>\n                            was isolated from the urine specimens of 146 patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            and 87 control subjects, and was analysed for total sialic acid (\n                            <jats:styled-content style=\"fixed-case\">SA<\/jats:styled-content>\n                            ) content by 1,2\u2010diamino\u20104,5\u2010methylenedioxybenzene. 2\n                            <jats:styled-content style=\"fixed-case\">HC<\/jats:styled-content>\n                            l (\n                            <jats:styled-content style=\"fixed-case\">DMB<\/jats:styled-content>\n                            )\u2010high performance liquid chromatography (\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            T\n                            <jats:styled-content style=\"fixed-case\">HP<\/jats:styled-content>\n                            \u2010associated metabolites were isolated by\n                            <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                            uperdex\u2010200 size\u2010exclusion chromatography (\n                            <jats:styled-content style=\"fixed-case\">SEC<\/jats:styled-content>\n                            ) as a second peak (\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2) and the\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2 was further fractionated into six major components by\n                            <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                            <jats:sub>18<\/jats:sub>\n                            reverse phase\u2010\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Ion\u2010pair\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            analysis was performed to identify and quantify\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            \u2010associated metabolites.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The metabolite structures were confirmed by reversed\u2010phase\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            combined with electrospray ionization (\n                            <jats:styled-content style=\"fixed-case\">ESI<\/jats:styled-content>\n                            ), liquid chromatography\u2010tandem mass spectrometry (\n                            <jats:styled-content style=\"fixed-case\">LC\u2010MS<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">LC\u2010MS<\/jats:styled-content>\n                            \/\n                            <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                            ) and by high\u2010resolution\n                            <jats:styled-content style=\"fixed-case\">ESI<\/jats:styled-content>\n                            \u2010time of flight mass spectrometry (\n                            <jats:styled-content style=\"fixed-case\">HR\u2010ESI<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">TOFMS<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            The\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            \u2010associated metabolites (\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2) were more prevalent in patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            than in the controls (40.4% vs 12.6%,\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001) as determined by\n                            <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                            uperdex\u2010200\n                            <jats:styled-content style=\"fixed-case\">SEC<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Superdex\u2010200\n                            <jats:styled-content style=\"fixed-case\">SEC<\/jats:styled-content>\n                            showed higher\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2 content in patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            than in controls, as determined by area under the peak\/100\u2009\u03bcg of\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            . The mean (\n                            <jats:sc>sem<\/jats:sc>\n                            ), for patients was 84.3 (8.1) vs 18.0 (2.4) milli\u2010absorption unit*min, for controls (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Total\n                            <jats:styled-content style=\"fixed-case\">SA<\/jats:styled-content>\n                            content of\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            was much lower in\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2\u2010positive patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            than those who were\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2\u2010negative. The mean (\n                            <jats:sc>sem<\/jats:sc>\n                            ) was 41.6 (3.2) vs 92.6 (2.2)\u2009nmol\/mg\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            , respectively (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Ion\u2010pair\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            identified\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2 metabolites as nucleotides, namely 5\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">CMP<\/jats:styled-content>\n                            , 3\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">UMP<\/jats:styled-content>\n                            , 3\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">AMP<\/jats:styled-content>\n                            , 3\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">GMP<\/jats:styled-content>\n                            , 2\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">AMP<\/jats:styled-content>\n                            and 2\u2032\u2010\n                            <jats:styled-content style=\"fixed-case\">GMP<\/jats:styled-content>\n                            . The total nucleotide content of\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2 was significantly higher in patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            than in controls. The mean (\n                            <jats:sc>sem<\/jats:sc>\n                            ) was 25.3 (2.9) vs 2.2 (0.2) \u03bcg\/mg\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            , respectively (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            L\n                            <jats:styled-content style=\"fixed-case\">C\u2010MS<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">LC\u2010MS<\/jats:styled-content>\n                            \/\n                            <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                            confirmed the nucleotides based on retention time on\n                            <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                            , and mass to charge ratio (m\/z) of the parent ion and the daughter ions. H\n                            <jats:styled-content style=\"fixed-case\">R\u2010ESI<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">TOFMS<\/jats:styled-content>\n                            gave further confimation of the nucleotide sturctures with high mass accuracy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            In the\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            of patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            , there is a direct correlation between reduced\n                            <jats:styled-content style=\"fixed-case\">SA<\/jats:styled-content>\n                            levels and high prevalence of nucleotides associated with it.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            of patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            has a much higher content of these nucleotides than control, and these unique nucleotide isomers identified are very consistent in all\n                            <jats:styled-content style=\"fixed-case\">SP<\/jats:styled-content>\n                            2\u2010positive patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            , suggesting biological significance.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            This study provides additional evidence that\n                            <jats:styled-content style=\"fixed-case\">THP<\/jats:styled-content>\n                            is abnormal in patients with\n                            <jats:styled-content style=\"fixed-case\">IC<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11691.x","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T14:02:33Z","timestamp":1361282553000},"page":"811-819","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tamm\u2010\n                    <scp>H<\/scp>\n                    orsfall protein\u2010associated nucleotides in patients with interstitial cystitis"],"prefix":"10.1111","volume":"111","author":[{"given":"Sulabha","family":"Argade","sequence":"first","affiliation":[{"name":"Division of Urology University of California (UC) San Diego Health System  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Shaw","sequence":"additional","affiliation":[{"name":"Division of Urology University of California (UC) San Diego Health System  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxuan","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry UC San Diego  La Jolla CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lowell","family":"Parsons","sequence":"additional","affiliation":[{"name":"Division of Urology University of California (UC) San Diego Health System  San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09843.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.03.084"},{"key":"e_1_2_7_4_1","first-page":"493","article-title":"Bladder surface glycosaminoglycans is a human epithelial permeability barrier","volume":"171","author":"Lilly JD","year":"1990","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)39897-X"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)63178-1"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67203-5"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2000.00165.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.05.021"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2409603"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-74-17825"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2560471.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.12.026"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.07.125"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.02.2699"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01829-0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)41529-1"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08163.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.146712"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.053876"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.178137"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01128-1"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65438-7"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-007-0083-7"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00366.x"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11691.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11691.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:01:20Z","timestamp":1761757280000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11691.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11691.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11691.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]},"assertion":[{"value":"2013-02-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}